Table 1.
Demographics of 30 eligible patients in retrospective study.
| Age at entry (years) | 46.1 ± 14.8 |
| Gender (M/F) | 12/18 |
| Disease extent | |
| Extensive | 5 |
| Left-sided | 12 |
| Proctitis | 13 |
| Dose of prior mesalazine (Pentasa) | |
| 2250 mg | 15 |
| 3000 mg | 3 |
| 4000 mg | 12 |
| Dose of switched mesalazine (Asacol) | |
| 2400 mg | 12 |
| 3600 mg | 18 |